Silexion Therapeutics Corp Ordinary Shares (SLXN) is a publicly traded Healthcare sector company. As of July 21, 2026, SLXN trades at $2.60 with a market cap of $2.74M and a P/E ratio of 0.10. SLXN moved -2.70% today. Year to date, SLXN is -85.03%; over the trailing twelve months it is -97.91%. Its 52-week range spans $2.31 to $634.50. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces SLXN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Silexion Therapeutics Corp Ordinary Shares (SLXN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SLXN moved -2.70% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.60 |
| Market Cap | $2.74M |
| P/E Ratio | 0.10 |
| EPS | $26.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $634.50 |
| 52-Week Low | $2.31 |
| Volume | 13.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $28.00K |
| Net Income | $-16.52M |
| Gross Margin | 0.00% |
1 analysts cover SLXN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.